Role of Ductus Venosus Doppler Sonography for the Prediction of Perinatal Outcome in Term Pregnancies Complicated by Gestational Diabetes Mellitus

Abstract

Purpose Ductus venosus (DV) Doppler velocimetry reflects fetal cardiac function. Gestational diabetes mellitus (GDM) is assumed to impair cardiac function due to fetal hyperglycemia. The purpose of this study was to assess the ability of DV Doppler to predict an adverse perinatal outcome (APO) in term pregnancies with GDM.

Methods This is a retrospective cohort study including GDM pregnancies of singleton, non-anomalous fetuses without any signs of placental dysfunction. All GDM women who primarily had a vaginal delivery attempt and in which DV Doppler was examined from 37+0 weeks on were included. Receiver operating characteristic curve (ROC) analyses were performed to assess the predictive value of DV pulsatility index (DV-PI) regarding a composite APO (CAPO). Furthermore, a subgroup analysis was performed regarding the presence of a large-for-gestational-age (LGA) newborn.

Results A total of n=89 cases were included. Overall, CAPO occurred in 26 out of 89 cases (29.2%). All DV Doppler examinations showed a positive A wave. DV-PI was>95th percentile in 8 out of 89 cases (9%). Overall, ROC analysis showed no significant association of DV-PI with CAPO (AUC=0.523, p=0.735). However, regarding individual APO parameters, ROC analysis showed a significant association of DV-PI with 5th-min AGPAR (AUC=0.960, p=0.027), which was not confirmed after exclusion of LGA cases.

Conclusion In GDM pregnancies at term, DV Doppler sonography seems to have no benefit for APO prediction.

Zusammenfassung

Ziel Der Ductus venosus (DV) Doppler spiegelt die fetale kardiale Funktion wider. Beim Gestationsdiabetes mellitus (GDM) kann die kardiale Funktion aufgrund einer fetalen Hyperglykämie beeinträchtigt sein. Das Ziel dieser Studie besteht darin, den prädiktiven Wert des DV-Doppler zur Vorhersage eines adversen perinatalen Outcomes (APO) bei GDM-Schwangerschaften in Terminnähe zu untersuchen. Material und

Methodik In diese retrospektive Kohortenstudie wurden GDM-Einlingsschwangerschaften ohne fetale Anomalien oder plazentare Dysfunktion eingeschlossen, bei denen ab 37+0 SSW eine DV-Doppler-Untersuchung durchgeführt und ein vaginaler Entbindungsversuch unternommen wurde. Es wurden Receiver Operating Characteristic Curves (ROC) eingesetzt, um den prädiktiven Wert des DV Pulsatilitätsindex (PI) bezogen auf ein zusammengesetztes APO (CAPO) zu bewerten. Eine Subgruppenanalyse erfolgte bezüglich des Vorhandenseins eines large-for-gestational-age (LGA) Neugeborenen.

Ergebnisse Insgesamt wurden n=89 Fälle eingeschlossen. Alle DV-Doppler-Untersuchungen zeigten eine positive a-Welle. Der DV-PI war in 8 von 89 Fällen (9%)>95. Perzentile. Die ROC- Analysen zeigten keinen signifikanten Zusammenhang von DV-PI mit CAPO (AUC=0,523, p=0,735). Bezüglich einzelner APO-Parameter zeigte die ROC-Analyse jedoch einen signifikanten Zusammenhang zwischen DV-PI und 5-Min-Apgar (AUC=0,960, p=0,027), der nach Ausschluss von LGA-Fällen nicht bestätigt wurde.

Schlussfolgerung Bei GDM-Schwangerschaften in Terminnähe scheint die DV-Doppler-Sonographie keinen Nutzen für die APO-Vorhersage zu haben.

Keywords

gestational diabetes mellitus - ductus venosus - doppler sonography - adverse perinatal outcome

Schlüsselwörter

Gestationsdiabetes mellitus - Ductus venosus - Dopplersonographie - adverses perinatales Outcome

Publikationsverlauf

Eingereicht: 25. September 2023

Angenommen nach Revision: 04. Februar 2024

Artikel online veröffentlicht:
22. März 2024

• References

• 1 S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge, 2. Auflage AWMF-Registernummer: 057–008 https://www.awmf.org/uploads/tx_szleitlinien/057-008l_S3_Gestationsdiabetes-mellitus-GDM-Diagnostik-Therapie-Nachsorge_2019-06.pdf
• 2 HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR. et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002 DOI: 10.1056/NEJMoa0707943.
• 3 Rane BM, Malau-Aduli BS, Alele F. et al. Prognostic accuracy of antenatal doppler ultrasound measures in predicting adverse perinatal outcomes for pregnancies complicated by diabetes: A systematic review. AJOG Glob Rep 2023; 3: 100241 DOI: 10.1016/j.xagr.2023.100241.
• 4 Hod M, Kapur A, Sacks DA. et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 2015; 131: S173-S211 DOI: 10.1016/S0020-7292(15)30033-3.
• 5 Faber R, Heling KS, Steiner H. et al. Dopplersonografie in der Schwangerschaft – Qualitätsanforderungen der DEGUM und klinischer Einsatz (Teil 1) Doppler Sonography during Pregnancy – DEGUM Quality Standards and Clinical Applications. Ultraschall Med. 2019. 40. 319-325 German: DOI: 10.1055/a-0800-8596
• 6 Crispi F, Gratacós E. Fetal cardiac function: technical considerations and potential research and clinical applications. Fetal Diagn Ther 2012; 32: 47-64 DOI: 10.1159/000338003.
• 7 Lees CC, Stampalija T, Baschat A. et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol 2020; 56: 298-312 DOI: 10.1002/uog.22134.
• 8 Depla AL, De Wit L, Steenhuis TJ. et al. Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2021; 57: 539-550 DOI: 10.1002/uog.22163.
• 9 Enzensberger C, Tenzer A, Degenhardt J. et al. Beurteilung der fetalen kardialen Funktion – etablierte und neue Methoden [Assessment of fetal cardiac function – established and novel methods]. Z Geburtshilfe Neonatol 2014; 218: 56-63 DOI: 10.1055/s-0034-1371849..
• 10 Graupner O, Meister M, Franz, C et al. (2021) VP37.06: Role of fetomaternal Doppler for the prediction of perinatal outcome in term pregnancies with gestational diabetes. Ultrasound Obstet Gynecol, 58: 254–254. https://doi.org/10.1002/uog.24554
• 11 Janbu T, Nesheim BI. Uterine artery blood velocities during contractions in pregnancy and labour related to intrauterine pressure. Br J Obstet Gynaecol 1987; 94: 1150-1155 DOI: 10.1111/j.1471-0528.1987. tb02314.x.
• 12 Hecher K, Campbell S, Snijders R. et al. Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 1994; 4: 381-390 DOI: 10.1046/j.1469-0705.1994.04050381.x.
• 13 Ayres-de-Campos D, Spong CY, Chandraharan E. FIGO Intrapartum Fetal Monitoring Expert Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. Int J Gynaecol Obstet 2015; 131: 13-24 DOI: 10.1016/j.ijgo.2015.06.020.
• 14 Edelstone DI, Rudolph AM. Preferential streaming of ductus venosus blood to the brain and heart in fetal lambs. Am J Physiol 1979; 237: H724-729 DOI: 10.1152/ajpheart.1979.237.6.H724.
• 15 Wong SF, Petersen SG, Idris N. et al. Ductus venosus velocimetry in monitoring pregnancy in women with pregestational diabetes mellitus. Ultrasound Obstet Gynecol 2010; 36: 350-354 DOI: 10.1002/uog.7744..
• 16 Kiserud T, Kessler J, Ebbing C. et al. Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 2006; 28: 143-149 DOI: 10.1002/uog.2784.
• 17 Lund A, Ebbing C, Rasmussen S. et al. Maternal diabetes alters the development of ductus venosus shunting in the fetus. Acta Obstet Gynecol Scand 2018; 97: 1032-1040 DOI: 10.1111/aogs.13363.
• 18 Morales-Roselló J, Bhate R, Eltaweel N. et al. Comparison of ductus venosus Doppler and cerebroplacental ratio for the prediction of adverse perinatal outcome in high-risk pregnancies before and after 34 weeks. Acta Obstet Gynecol Scand 2023; 102: 891-904 DOI: 10.1111/aogs.14570.
• 19 Taricco E, Radaelli T, Rossi G. et al. Effects of gestational diabetes on fetal oxygen and glucose levels in vivo. BJOG 2009; 116: 1729-1735 DOI: 10.1111/j.1471-0528.2009.02341.x.
• 20 Stuart A, Amer-Wåhlin I, Gudmundsson S. et al. Ductus venosus blood flow velocity waveform in diabetic pregnancies. Ultrasound Obstet Gynecol 2010; 36: 344-349 DOI: 10.1002/uog.7573..
• 21 Wong SF, Chan FY, Cincotta RB. et al. Cardiac function in fetuses of poorly-controlled pre-gestational diabetic pregnancies – a pilot study. Gynecol Obstet Invest 2003; 56: 113-116 DOI: 10.1159/000073191.
• 22 Zielinsky P, Marcantonio S, Nicoloso LH. et al. Ductus venosus flow and myocardial hypertrophy in fetuses of diabetic mothers. Arq Bras Cardiol 2004; 83: 45-50 DOI: 10.1590/s0066-782x2004001300005.
• 23 Hecher K, Snijders R, Campbell S. et al. Fetal venous, intracardiac, and arterial blood flow measurements in intrauterine growth retardation: relationship with fetal blood gases. Am J Obstet Gynecol 1995; 173: 10-15 DOI: 10.1016/0002-9378(95)90161-2.